Study on the implementation of using electronic medicine box to assist drug taking management of pulmonary tuberculosis patients

doi:10.19982/j.issn.1000-6621.20210339

Abstract

Abstract:

From July 2018 to June 2019, 1488 tuberculosis patients were diagnosed in Quzhou City, and a kind of electronic medicine box was recommended to them for voluntarily adoption. 915 patients (61.49%) chose to use the electronic medicine box. 79.34% (726/915) of them persisted to use it at the end of 2 months’ treatment, 66.01% (604/915) persisted at the end of 4 months’ treatment, and 52.35% (479/915) persisted at the end of 6 months’ treatment. There were statistical differences ( $χ trend 2$ =586.924, P=0.001). The adoption rate of electronic medicine box for pulmonary tuberculosis patients needs to be improved, and the persistance of using it will decline as the use time increases.

Key words: tuberculosis,lung, electronic pill box, utilization rate, medication management

CLC Number:

R521

HAO Xiao-gang, WANG Wei, ZHANG Xing, ZHU Ping, XU Chun-feng. Study on the implementation of using electronic medicine box to assist drug taking management of pulmonary tuberculosis patients[J]. Chinese Journal of Antituberculosis, 2022, 44(1): 110-112. doi: 10.19982/j.issn.1000-6621.20210339

Figures/Tables 2

References 9

[1]	Manyazewal T, Woldeamanuel Y, Holland DP, et al. Electronic pillbox-enabled self-administered therapy versus standard directly observed therapy for tuberculosis medication adherence and treatment outcomes in Ethiopia (SELFTB): protocol for a multicenter randomized controlled trial. Trials, 2020, 21(1):383. doi: 10.1186/s13063-020-04324-z. doi: 10.1186/s13063-020-04324-z pmid: 32370774
[2]	彭红, 陆伟, 竺丽梅, 等. 江苏省肺结核患者电子药盒的取药记录与实际服药的一致性研究. 江苏预防医学, 2013, 24(1):13-16.doi: 10.3969/j.issn.1006-9070.2013.01.005. doi: 10.3969/j.issn.1006-9070.2013.01.005
[3]	桓世彤, 陈嵘, 刘小秋, 等. 电子药盒取药记录监测肺结核患者服药行为的可行性评估. 中国防痨杂志, 2012, 34(7):419-424.
[4]	陈松华, 王晓萌, 柴程良, 等. 浅谈“三位一体”结核病防治服务体系建设. 中国防痨杂志, 2016, 38(6):428-431.doi: 10.3969/j.issn.1000-6621.2016.06.002. doi: 10.3969/j.issn.1000-6621.2016.06.002
[5]	胡代玉, 汪涛, 刘晓云, 等. 重庆市涂阳肺结核病人直接面视下服药的实施现状与影响因素分析. 中国卫生资源, 2006, 9(5):219-221.
[6]	戴冰, 陈召青, 沈经纬, 等. 江苏省镇江市肺结核患者电子药盒管理模式评估. 中国热带医学, 2020, 20(2):185-188.doi: 10.13604/j.cnki.46-1064/r.2020.02.22. doi: 10.13604/j.cnki.46-1064/r.2020.02.22
[7]	王倪, 张慧, 张铁娟, 等. 使用电子药盒辅助肺结核患者服药管理的实施情况分析. 中国防痨杂志, 2020, 42(7):682-686.doi: 10.3969/j.issn.1000-6621.2020.07.008. doi: 10.3969/j.issn.1000-6621.2020.07.008
[8]	王倪, 黄飞, 张慧. 电子药盒在结核病患者服药管理中的应用与进展. 结核病与肺部健康杂志, 2019, 8(4):244-247. doi: 10.3969/j.issn.2095-3755.2019.04.003. doi: 10.3969/j.issn.2095-3755.2019.04.003
[9]	徐红, 陆峰. 运用电子药盒管理肺结核患者依从性分析. 江苏预防医学, 2013, 24(1):51-52.doi: 10.3969/j.issn.1006-9070.2013.01.023. doi: 10.3969/j.issn.1006-9070.2013.01.023

特征	登记例数	使用药盒例数	使用率(%)	χ²值	P值
性别				0.177	0.674
男性	1061	656	61.83
女性	427	259	60.66
年龄组(岁)				39.901	0.000
1219	43	32	74.42
2039	231	142	61.47
4059	366	248	67.76
6079	677	423	62.48
8094	171	70	40.94
地区				197.273	0.001
柯城区	499	214	42.89
衢江区	70	57	81.43
常山县	249	222	89.16
开化县	156	106	67.95
龙游县	166	130	78.31
江山市	348	186	53.45
合计	1488	915	61.49

地区	开始治疗		治疗2个月		治疗4个月		治疗6个月
地区	例数	使用率(%)	例数	使用率(%)	例数	使用率(%)	例数	使用率(%)
柯城区	214	100.00	156	72.90	111	51.87	77	35.98
衢江区	57	100.00	45	78.95	43	75.44	42	73.68
常山县	222	100.00	196	88.29	169	76.13	134	60.36
开化县	106	100.00	97	91.51	90	84.91	79	74.53
龙游县	130	100.00	122	93.85	108	83.08	90	69.23
江山市	186	100.00	110	59.14	83	44.62	57	30.65
合计	915	100.00	726	79.34	604	66.01	479	52.35

[1]	Li Min, Yao Yushan, Qiao Haixia, Lei Hong. Association between pulmonary tuberculosis and the gut microbiota: treatment strategies [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 520-526.
[2]	Feng Wei, Zheng Hailun, Meng Weili, Luo Ping. Analysis of under-reporting before arrival of pulmonary tuberculosis patients registered and managed by Tuberculosis Prevention and Control Institutions in Xicheng District, Beijing from 2018 to 2023 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 439-443.
[3]	Song Yunlin, Buzukela Abuduaini, Wang Guirong, Zhang Jiyuan, Lu Xiaobo. Research progresses on the role and mechanism of calcium-binding protein S100A12 and neutrophil extracellular trap formation in lung injury of severe pulmonary tuberculosis patients [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 513-519.
[4]	Li Yuhong, Mei Jinzhou, Su Wei, Ruan Yunzhou, Liu Yushu, Zhao Yanlin, Liu Xiaoqiu. Analysis of the treatment outcomes and influencing factors of rifampicin-resistant pulmonary tuberculosis patients aged 65 and above in China from 2015 to 2021 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 408-415.
[5]	Jiang Xue, Bai Yunlong, Ma Jianjun, An Yuan, Yang Fan, Zhao Qinglong. Status and influencing factors of diagnosis and treatment delay of rifampicin resistant pulmonary tuberculosis patients, Jilin Province, 2020—2023 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 416-424.
[6]	An Yuan, Bai Yunlong, Zhao Qinglong, Ma Jianjun, Jiang Xue, Pan Yan, Gao Ying, Gao Zhihui. Analysis of treatment outcomes and influencing factors of patients with pulmonary tuberculosis complicated with diabetes mellitus in Jilin Province,2018—2022 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 432-438.
[7]	Li Leilei, Shi Lei, Wang Lin, Li Hongwei, Xu Liran, Pang Yu, Song Yanzheng. Clinical characteristics analysis of HIV-infected cases diagnosed with tuberculosis after surgery due to pulmonary nodules [J]. Chinese Journal of Antituberculosis, 2025, 47(3): 266-273.
[8]	Gong Sheng, Wang Ning, Li Dan, Li Gang, Liu Yu, Jiang Liangshuang, Yao Xiaojun. Comparative study of fluorescence staining method and inflation-deflation method for thoracoscopic pulmonary tuberculosis segmentectomy [J]. Chinese Journal of Antituberculosis, 2025, 47(3): 292-297.
[9]	Shi Yuru, Gu Dejian, Wu Jing, Liu Ting, Qin Linghan, Yue Li, Qi Yingjie. Diagnostic value of probe capture-based targeted next-generation sequencing and metagenomic next-generation sequencing for detecting Mycobacterium tuberculosis in bronchoalveolar lavage fluid [J]. Chinese Journal of Antituberculosis, 2025, 47(3): 305-311.
[10]	Song Feier, Mao Yanjun, Xia Qiuyue, Zhou Yang, Lin Huan. The prevalence and influencing factors of post-tuberculosis lung disease: A Meta-analysis [J]. Chinese Journal of Antituberculosis, 2025, 47(3): 322-330.
[11]	Yang Haixia, Zhang Xiaoyan, Huang Yi, Li Qiu. Effective and safety of concurrent intensity-modulated radiotherapy and anti-tuberculosis chemotherapy in patients with active pulmonary tuberculosis comorbid with thoracic tumor [J]. Chinese Journal of Antituberculosis, 2025, 47(3): 312-321.
[12]	Li Xuelian, Zhang Hongyan, Wang Jun, Wang Qingfeng, Ma Liping, Chu Naihui, Nie Wenjuan. Safety of extended delamanid use in drug-resistant tuberculosis patients [J]. Chinese Journal of Antituberculosis, 2025, 47(2): 164-168.
[13]	Gao Li, Chen Shengyu, Zhang Wenqian, Li Dan, Zhang Guoqin. Investigation on ability of conducting tuberculosis surveillance among four types of high-risk population in Tianjin public hospitals [J]. Chinese Journal of Antituberculosis, 2025, 47(2): 195-200.
[14]	Wang Dafu, Ma Xiaoxue, Wang Yun, Li Fudong, Rao Wen, Gong Tingting, Li Shijun, Li Jinlan. Analysis of risk factors for patient delay and adverse treatment outcomes among patients with pulmonary tuberculosis and diabetes mellitus in Guizhou Province, 2016—2023 [J]. Chinese Journal of Antituberculosis, 2025, 47(2): 201-209.
[15]	Qiu Yong, Quan Zhuo, Qu Rong, Tian Fajun, Li Meng, Wang Gengsheng, Wang Ya, Guo Mingcheng, Gao Qian. Evaluation of different tuberculosis diagnostic tools for detecting patients in a primary-level clinic in rural China: a real-world retrospective study [J]. Chinese Journal of Antituberculosis, 2025, 47(2): 181-188.